Targeting cullin neddylation for cancer and fibrotic diseases
Theranostics · 2023 · 13 (14) · 5017-5056
DOI: 10.7150/thno.78876 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2023. Verfasst von Zhang-Xu He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy College, Henan University of Chinese Medicine, 450046, Zhengzhou, China. Hauptthemen laut MEDLINE: Neoplasms, Lymphoma. Die Arbeit wurde bisher 51-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Protein neddylation is a post-translational modification, and its best recognized substrates are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs). Given that most neddylation pathway proteins are overactivated in different cancers and fibrotic diseases, targeting neddylation becomes an emerging approach for the treatment of these diseases. To date, numerous neddylation inhibitors have been developed, of which MLN4924 has entered phase I/II/III clinical trials for cancer treatment, such as acute myeloid leukemia, melanoma, lymphoma and solid tumors. Here, we systematically describe the structures and biological functions of the critical enzymes in neddylation, highlight the medicinal chemistry advances in the development of neddylation inhibitors and propose the perspectives concerning targeting neddylation for cancer and fibrotic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy College, Henan University of Chinese Medicine, 450046, Zhengzhou, China.
- State Key Laboratory of Esophageal Cancer Prevention and Treatment; Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzho…
- Children's hospital affiliated of Zhengzhou university; Henan children's hospital; Zhengzhou children's hospital, Henan Zhengzhou 450000, China.
- China Meheco Topfond Pharmaceutical Co., Zhumadian 463000, China.
- Key Laboratory of Cardio-cerebrovascular Drug, Henan Province, Zhumadian 463000, China.
Zitieren
APA
He, Z. X., Yang, W. G., Zengyangzong, D., Gao, G., Zhang, Q., Liu, H. M., Zhao, W., & Ma, L. Y. (2023). Targeting cullin neddylation for cancer and fibrotic diseases. Theranostics, 13(14), 5017-5056. https://doi.org/10.7150/thno.78876
Vancouver
He ZX, Yang WG, Zengyangzong D, Gao G, Zhang Q, Liu HM, et al. Targeting cullin neddylation for cancer and fibrotic diseases. Theranostics. 2023;13(14):5017-5056. doi:10.7150/thno.78876
BibTeX
@article{He2023,
author = {He, Zhang-Xu and Yang, Wei-Guang and Zengyangzong, Dan and Gao, Ge and Zhang, Qian and Liu, Hong-Min and Zhao, Wen and Ma, Li-Ying},
title = {Targeting cullin neddylation for cancer and fibrotic diseases},
journal = {Theranostics},
year = {2023},
volume = {13},
number = {14},
pages = {5017--5056},
doi = {10.7150/thno.78876}
}
EUVIMED